[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,195
Sort by:
North America: Vitamins Market US$ 1,999.00

... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...

August 2022 150 pages
Global CD47 Inhibitor Drug Clinical Trials Insight 2028 US$ 2,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global CD47 Inhibitor Drug Clinical Trials Insight 2028 Report Highlights:CD47 Inhibitor...

August 2022 132 pages
Vitamins China E-News 202207 US$ 3,186.00

... Dec. Issue of Vitamins China E-News. This newsletter will ... increasingly stringent environmental regulations in China. On 25 Dec., 2016, the first Environmental Protection Tax Law in China was approved ... were witnessed in prices of several vitamins, such as VC, calcium pantothenate, VB1 and VB12. As the ...

July 2022 36 pages
Investigation Report on China's Infliximab Market 2022-2031 US$ 3,200.00

... ankylosing spondylitis and Crohn's disease. By Oct. 2018, China's Infliximab market is monopolized by Remicade imported by Xi'an Janssen Pharmaceutical ... spondylitis and Crohn's disease in China Sales of Infliximab in China Prices of Infliximab in China Forecast on China's Infliximab market from 2018 to 2022

July 2022 40 pages
Investigation Report on China's Aflibercept Market 2022-2031 US$ 3,200.00

Aflibercept is an anti-VEGF drug, mainly used to treat neovascular age-related macular degeneration (wAMD), and other retinopathy caused by visual impairment. Aflibercept was jointly developed by Rege...

July 2022 40 pages
Research Report on China's Nicorandil Market, 2022-2031 US$ 3,600.00

In China, the crude incidence rate of hypertension among residents over the age of 18 is close to 30%, and the most common hazard of hypertension is coronary heart disease. By the end of 2021, it is e...

July 2022 50 pages
Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Software, Service), Method (DNA Methylation), Technique (NGS, PCR & qPCR), Application (Oncology, Immunology), End User - Global Forecast to 2027 US$ 4,950.00

... in the epigenetics market Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the epigenetics market Market Development: Comprehensive ...

July 2022 239 pages
TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 US$ 3,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. TIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 Report Highlights:...

July 2022 111 pages
The 2023-2028 World Outlook for Biocompatible Materials US$ 995.00

This study covers the world outlook for biocompatible materials across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for biocompatible materials. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

June 2022 288 pages
The 2023-2028 World Outlook for Mexican Cooking Sauces US$ 995.00

This study covers the world outlook for Mexican cooking sauces across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Mexican cooking sauces. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

June 2022 287 pages
The 2023-2028 World Outlook for Vehicle Bodies and Trailers US$ 995.00

... study covers the world outlook for vehicle bodies and trailers across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for vehicle bodies and trailers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

June 2022 288 pages
The 2023-2028 World Outlook for Consumer Electronic Wireless Chargers US$ 995.00

This study covers the world outlook for consumer electronic wireless chargers across more than 190 countries. For each year ... demand, or the P.I.E., for consumer electronic wireless chargers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

June 2022 290 pages
The 2023-2028 World Outlook for Nail Care Products US$ 995.00

This study covers the world outlook for nail care products across more than 190 countries. For each year reported, ... latent demand, or the P.I.E., for nail care products. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

June 2022 287 pages
The 2023-2028 World Outlook for Pay TV Services US$ 995.00

This study covers the world outlook for pay TV services across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for pay TV services. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...

June 2022 288 pages
The 2023-2028 World Outlook for Private Utility Wireless Communication Nodes US$ 995.00

This study covers the world outlook for private utility wireless communication nodes across more than 190 countries. For each ... demand, or the P.I.E., for private utility wireless communication nodes. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

June 2022 294 pages
The 2023-2028 World Outlook for Semiconductor Fabrication Materials US$ 995.00

This study covers the world outlook for semiconductor fabrication materials across more than 190 countries. For each year reported, ... demand, or the P.I.E., for semiconductor fabrication materials. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

June 2022 290 pages
The 2023-2028 World Outlook for Thermocouples US$ 995.00

This study covers the world outlook for thermocouples across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...

June 2022 287 pages
Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Acromegaly Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acro...

June 2022 78 pages
Alcoholic Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Alcoholic Hepatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline g...

June 2022 74 pages
Axillary Hyperhidrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Axillary Hyperhidrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipelin...

June 2022 43 pages
Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipel...

June 2022 31 pages
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY C-C Chemokine Receptor...

June 2022 52 pages
Calcitonin Gene Related Peptide (CGRP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

Calcitonin Gene Related Peptide (CGRP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Calcitonin Gene Related Peptide (CGRP...

June 2022 79 pages
Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Celiac Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...

June 2022 122 pages
Chlamydia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Chlamydia Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

June 2022 67 pages
Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Choles...

June 2022 45 pages
Contact Dermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Contact Dermatitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gu...

June 2022 43 pages
Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,500.00

Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gui...

June 2022 844 pages
Fragile X Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Fragile X Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gu...

June 2022 126 pages
Gastric Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Gastric Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...

June 2022 53 pages
Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,500.00

Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glauco...

June 2022 347 pages
Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gu...

June 2022 230 pages
Graft Versus Host Disease (GVHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,500.00

Graft Versus Host Disease (GVHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disea...

June 2022 636 pages
Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Hemophilia B (Factor IX Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare di...

June 2022 149 pages
Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Hepa...

June 2022 60 pages
Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,500.00

Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hep...

June 2022 340 pages
Herpes Zoster (Shingles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Herpes Zoster (Shingles) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipel...

June 2022 86 pages
High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

June 2022 51 pages
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Typ...

June 2022 47 pages
Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,500.00

Human Papillomavirus (HPV) Associated Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Heal...

June 2022 260 pages
Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY According to the recently pub...

June 2022 85 pages
Hyperuricemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Hyperuricemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide H...

June 2022 93 pages
Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,500.00

Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare d...

June 2022 292 pages
Leber Congenital Amaurosis (LCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Leber Congenital Amaurosis (LCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disea...

June 2022 60 pages
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceut...

June 2022 68 pages
Liver Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Liver Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pip...

June 2022 49 pages
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 3,500.00

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

June 2022 81 pages
Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update US$ 2,000.00

Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neu...

June 2022 102 pages

Filters

Search

Publishers

1
38
1
4
8
27
4
165
2
1,957
5
174
29
4
22
51
6
142
1
17
1
15
15
11
651
35
1
373
16
586
4
1
1
2
16
1,197
6
166
4
84
31
2
36
3
5
4
118
187
13
16
4
2
7
15
110
2
10
43
16
22
4
2
17
4
2
1
11
32
7
11
4
30
118
37
2
1
19
4
7
3
324
8
1
1
23
31
4
11
4
1
515
24
2
5
28
44
290
17
17
13
5
19
2

Regions

5
6
6
4
9
12
4
11
9
11
5
8
9
5
9
8
7
682
274
162
55
51
45
45
43
41
21
18
18
17
17
16
15
15
14
14
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
12
12
11
11
11
10
10
9
8
8
7
6
6
5
4
3
192
10
8
4
4
4
4
4
3
3
3
3
3
3
1
1
183
3
11
14
11
16
9
6
16
15
7
150
247
5,129

Price

Date

Pages

Offers

1
1
514